Article Details

WashU COVID-19 nasal vaccine technology licensed to Ocugen

Retrieved on: 2022-10-04 19:19:41

Tags for this article:

Click the tags to see associated articles and topics

WashU COVID-19 nasal vaccine technology licensed to Ocugen. View article details on hiswai:

Excerpt

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is on the path to becoming available in the ...

Article found on: medicine.wustl.edu

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up